Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fasting Conditions [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetics and safety of BR3409, alone and in combination with BR3409-1 and BR3409-2, in healthy volunteers under fasting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BR3409
• BR3409-1
• BR3409-2

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED